MIF and rheumatoid arthritis: Additionally, a significant increase of MIF levels in RA patients with moderate disease activity (DAS28 ≥ 3.2 to ≤5.1) versus those with low disease activity (DAS28 ≥ 2.6 to <3.2) was found (Figure 2b, p = .03).